132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN – an EORTC-SPECTA and EURACAN study

التفاصيل البيبلوغرافية
العنوان: 132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN – an EORTC-SPECTA and EURACAN study
المؤلفون: Morfouace, M., Oliveira, J., Penel, N., Peron, J., Pracht, M., Brasiuniene, B., Capela Marques, A., Gennigens, Christine, Greillier, L., Robert, M-S., Klumpen, H.J., Peeters, R., Licitra, L.F.L., Girard, N., Gietema, J.A., de Herder, W., Kapiteijn, E., Idbaih, A., Ray-Coquard, I.L., Blay, J-Y.
المصدر: Annals of Oncology, 34, S233-S234 (2023-10); ESMO Congress 2023, Madrid, Spain [ES], 20-24 October 2023
بيانات النشر: Elsevier BV, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Oncology, Hematology, Human health sciences, Sciences de la santé humaine, Oncologie
نوع الوثيقة: conference paper
http://purl.org/coar/resource_type/c_5794
conferenceObject
peer reviewed
اللغة: English
Relation: https://api.elsevier.com/content/article/PII:S0923753423036943?httpAccept=text/xml; urn:issn:0923-7534; urn:issn:1569-8041
DOI: 10.1016/j.annonc.2023.09.2857
URL الوصول: https://orbi.uliege.be/handle/2268/308605
حقوق: restricted access
http://purl.org/coar/access_right/c_16ec
info:eu-repo/semantics/restrictedAccess
رقم الأكسشن: edsorb.308605
قاعدة البيانات: ORBi
الوصف
DOI:10.1016/j.annonc.2023.09.2857